Above results we noticed that IL4R, IL2RB and NAT2, which were differentially expressed in CRC tumor, significantly affect both pathological stages and prognosis of CRC patients, collectively (Fig. 2A). The gene discussed is NAT2; the disease is colorectal carcinoma.